Efficacy and safety of edoxaban tosylate hydrate 15 mg in the prevention of venous thromboembolism in patients with impaired renal function after orthopedic surgery of the lower extremities
Abstract Background Although not indicated in the USA, edoxaban tosylate hydrate 15 mg is used for venous thromboembolism (VTE) prophylaxis after orthopedic surgery of the lower extremities in Japan. However, its efficacy and safety in patients with impaired renal function have not been fully evalua...
Main Authors: | Teruhisa Kinoshita, Sayuri Otsuka, Shota Torii, Yoko Tsugeno, Shiori Fukaya, Mari Sobue, Ayumi Ishihara, Takashi Sakakibara, Norio Takimoto |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-12-01
|
Series: | Renal Replacement Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s41100-021-00387-z |
Similar Items
-
Periinterventional Management of Edoxaban in Major Procedures: Results from the DRESDEN NOAC REGISTRY
by: Christina Köhler, et al.
Published: (2023-07-01) -
Feasibility of edoxaban for asymptomatic cancer-associated thrombosis in Japanese patients with gastrointestinal cancer: ExCAVE study
by: Michio Nakamura, et al.
Published: (2022-12-01) -
Treatment of Alcohols with Tosyl Chloride Does Not always Lead to the Formation of Tosylates
by: Chuanmin Qi, et al.
Published: (2011-07-01) -
Efficacy and Safety of Edoxaban in Cancer-Associated Venous Thromboembolism: A Real World Retrospective Study
by: Elisa Grifoni, et al.
Published: (2022-04-01) -
Risk impact of edoxaban in the management of stroke and venous thromboembolism
by: Hurst KV, et al.
Published: (2016-08-01)